Ecolab (ECL) said Wednesday it has opened a new facility in King of Prussia, Pennsylvania, to assist biopharmaceutical companies and contract manufacturers with applications and process development of therapeutic molecules.
The site offers process development tools and chromatography columns for drug developers from the early stage of development to commercialization, the company said.
Ecolab said the lab is intended to help clients cut costs, streamline production, and prepare documentation for regulatory submission.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.